132 related articles for article (PubMed ID: 7990972)
1. Characteristics of tail-tremor induced by nicotine in rats.
Suemaru K; Oishi R; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):153-7. PubMed ID: 7990972
[TBL] [Abstract][Full Text] [Related]
2. Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Suemaru K; Kawasaki H; Oishi R; Gomita Y; Tanizaki Y
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):571-5. PubMed ID: 9151294
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-induced tail-tremor and drug effects.
Gomita Y; Suemaru K; Furuno K; Araki Y
Pharmacol Biochem Behav; 1989 Dec; 34(4):817-21. PubMed ID: 2576144
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.
Suemaru K; Kawakami Y; Araki H; Gomita Y; Tanizaki Y
Acta Med Okayama; 1998 Feb; 52(1):49-53. PubMed ID: 9548994
[TBL] [Abstract][Full Text] [Related]
5. Involvement of nitric oxide in development of tail-tremor induced by repeated nicotine administration in rats.
Suemaru K; Kawasaki H; Gomita Y; Tanizaki Y
Eur J Pharmacol; 1997 Sep; 335(2-3):139-43. PubMed ID: 9369366
[TBL] [Abstract][Full Text] [Related]
6. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade.
Ericson M; Olausson P; Engel JA; Söderpalm B
Eur J Pharmacol; 2000 May; 397(1):103-11. PubMed ID: 10844104
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model].
Suemaru K; Kawasaki H; Gomita Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):123-7. PubMed ID: 9278937
[TBL] [Abstract][Full Text] [Related]
8. Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats.
Suemaru K; Araki H; Gomita Y
Eur J Pharmacol; 2000 Nov; 408(1):19-23. PubMed ID: 11070179
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.
Benwell ME; Balfour DJ; Birrell CE
Br J Pharmacol; 1995 Jan; 114(2):454-60. PubMed ID: 7881744
[TBL] [Abstract][Full Text] [Related]
10. Tail-tremor induced by exposure to cigarette smoke in rats.
Gomita Y; Suemaru K; Furuno K; Araki Y
Pharmacol Biochem Behav; 1991 Oct; 40(2):453-5. PubMed ID: 1805247
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of anti-tremorogenic drugs using nicotine-induced tail-tremor model and elucidation of the mechanism].
Suemaru K; Araki H; Gomita Y
Yakugaku Zasshi; 2001 Apr; 121(4):259-64. PubMed ID: 11305042
[TBL] [Abstract][Full Text] [Related]
12. Individual differences in rat locomotor activity are diminished by nicotine through stimulation of central nicotinic acetylcholine receptors.
Bevins RA; Besheer J
Physiol Behav; 2001 Jan; 72(1-2):237-44. PubMed ID: 11240002
[TBL] [Abstract][Full Text] [Related]
13. Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.
O'Neill MF; Fernández AG; Gristwood RW; Palacios JM
J Neural Transm Gen Sect; 1994; 96(1):9-18. PubMed ID: 7857593
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
Suemaru K; Gomita Y; Furuno K; Araki Y
Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
[TBL] [Abstract][Full Text] [Related]
15. Reboxetine: attenuation of intravenous nicotine self-administration in rats.
Rauhut AS; Mullins SN; Dwoskin LP; Bardo MT
J Pharmacol Exp Ther; 2002 Nov; 303(2):664-72. PubMed ID: 12388649
[TBL] [Abstract][Full Text] [Related]
16. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice.
Zarrindast MR; Homayoun H; Babaie A; Etminani A; Gharib B
Eur J Pharmacol; 2000 Oct; 407(1-2):145-58. PubMed ID: 11050302
[TBL] [Abstract][Full Text] [Related]
17. Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats.
Coolon RA; Cain ME
Pharmacol Biochem Behav; 2009 Jul; 93(1):59-66. PubMed ID: 19379770
[TBL] [Abstract][Full Text] [Related]
18. The importance of nucleus accumbens in nicotine-induced locomotor activity.
Fung YK
J Pharm Pharmacol; 1990 Aug; 42(8):595-6. PubMed ID: 1981594
[TBL] [Abstract][Full Text] [Related]
19. [Nicotine-induced ambulatory stimulant effect and its reverse tolerance].
Kita T; Okamoto M; Nakashima T
Yakubutsu Seishin Kodo; 1992 Feb; 12(1):17-25. PubMed ID: 1414027
[TBL] [Abstract][Full Text] [Related]
20. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
Kempsill FE; Pratt JA
Br J Pharmacol; 2000 Nov; 131(5):997-1003. PubMed ID: 11053222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
